Hypertension treatment results in minority patients.
The limited data available from the long-term clinical trials on the treatment of hypertension, as well as several short-term studies, indicate that the lowering of blood pressure in minority patients is feasible over the long term with a marked decrease in morbidity and mortality. The presence of left ventricular hypertrophy and diabetes in a higher number of black compared with white patients does not appear to be a major determining factor in the choice of initial monotherapy. Studies have established that the blood pressure-lowering effects of thiazide diuretics and calcium entry blockers or converting enzyme inhibitors. When these latter agents are added to a diuretic, however, a good blood pressure response is achieved. There are few data available on the results of long-term treatment in Asian or Hispanic persons.
Moser
M
M
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
D001741:Black or African American; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006332:Cardiomegaly / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000208:ethnology* / Q000628:therapy; D008297:Male
D002121:Calcium Channel Blockers; D004232:Diuretics